Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib in Advanced COVID-19
NCT04372602Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duvelisib in coronavirus disease 2019 (COVID-19), sponsored by Washington University School of Medicine. Started Oct 2020; status: completed.
02
Drugs
duvelisib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04372602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372602.